SCHEMBL30210902

SCHEMBL30210902

C[C@H](C(N)=O)N(c1ccc(F)cc1)c1nc(N)c(C(=O)c2cc(C(=O)Nc3ccccn3)no2)s1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
CDK5 Q00535 7/20 0.42
CDK5R1 Q15078 7/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
GRM5 P41594 5/20 0.38
TP53 P04637 1/20 0.35
PKM P14618 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
XIAP P98170 1/20 0.34
BIRC2 Q13490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930561 1.00 SMN1; SMN2 (0.44) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL23930513 0.90 SMN1; SMN2 (0.42) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL30210824 0.90 SMN1; SMN2 (0.42) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL30210967 0.88 SMN1; SMN2 (0.42) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL23930524 0.88 SMN1; SMN2 (0.42) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL23930506 0.86 TDP1 (0.49) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL30210896 0.86 TDP1 (0.49) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL23930498 0.86 MAPT (0.38) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL30210848 0.86 MAPT (0.38) SMN1; SMN2CDK5CDK5R1NPC1RAB9A
SCHEMBL23930521 0.85 SMN1; SMN2 (0.39) SMN1; SMN2CDK5CDK5R1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697979-B Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2025-06-24 CN claimed
EP-4139287-B1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AG (DE) 2025-02-26 EP claimed
EP-4139287-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2023-03-01 EP claimed
EP-4139287-B1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AG (DE) 2025-02-26 EP disclosed